Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Paediatric Leukemia

Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience

Bone Marrow Transplantation volume 33, pages 805–814 (2004)Cite this article

Summary:

The purpose of this study was to evaluate the role of allogeneic bone marrow transplantation (BMT) in children with myelodysplastic syndrome (MDS). In total, 94 consecutive pediatric patients with MDS received an allogeneic BMT from 1976 to 2001 for refractory anemia (RA) (n=25), RA with ringed sideroblasts (RARS) (n=2), RA with excess blasts (RAEB) (n=20), RAEB in transformation (RAEB-T) (n=14), juvenile myelomonocytic leukemia (JMML) (n=32) or chronic myelomonocytic leukemia (CMML) (n=1). The estimated 3-year probabilities of survival, event-free survival (EFS), nonrelapse mortality and relapse were 50, 41, 28 and 29%, respectively. Patients with RA/RARS had an estimated 3-year survival of 74% compared to 68% in those with RAEB and 33% in patients with JMML/CMML. In multivariable analysis, patients with RAEB-T or JMML were 3.9 and 3.7 times more likely to die compared to those with RA/RARS and RAEB (P=0.005 and 0.004, respectively). Patients with RAEB-T were 5.5 times more likely to relapse (P=0.01). The median follow-up among the 43 surviving patients is 10 years (range 1–25). We conclude that allogeneic BMT for children with MDS is well tolerated and can be curative.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Kobrinsky NIL, Nesbit Jr MIE, Ramsay NK et al. Hematopoietic dysplasia and marrow hypocellularity in children: a preleukemic condition. J Pediatr 1982; 10: 907–913.

    Article  Google Scholar 

  2. Gadner H, Haas OA . Experience in pediatric myelodysplastic syndromes. Hematol Oncol Clin North Am 1992; 6: 655–672.

    Article  CAS  PubMed  Google Scholar 

  3. Passmore SJ, Hann IM, Stiller CA et al. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood 1995; 85: 1742–1750.

    CAS  PubMed  Google Scholar 

  4. Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189–199.

    Article  CAS  PubMed  Google Scholar 

  5. Woods WG, Barnard DR, Alonzo TA et al. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the children's cancer group. J Clin Oncol 2002; 20: 434–440.

    PubMed  Google Scholar 

  6. Tuncer MA, Pagliuca A, Hicsonmez G et al. Primary myelodysplastic syndrome in children: the clinical experience in 33 cases. Br J Haematol 1992; 82: 347–353.

    Article  CAS  PubMed  Google Scholar 

  7. Creutzig U, Cantu-Rajnoldi A, Ritter J et al. Myelodysplastic syndromes in childhood. Report of 21 patients from Italy and West Germany. Am J Pediatr Hematol Oncol 1987; 9: 324–330.

    Article  CAS  PubMed  Google Scholar 

  8. Hasle H . Myelodysplastic syndromes in childhood – classification, epidemiology, and treatment. Leuk Lymphoma 1994; 13: 11–26.

    Article  CAS  PubMed  Google Scholar 

  9. Wegelius R . Preleukaemic states in children. Scan J Haematol Supple 1986; 45: 133–139.

    CAS  Google Scholar 

  10. Martinez-Climent JA . Molecular cytogenetics of childhood hematological malignancies. Leukemia 1997; 11: 1999–2021.

    Article  CAS  PubMed  Google Scholar 

  11. Nowell PC . Cytogenetics of preleukemia. Cancer Genet Cytogenet 1982; 5: 265–278.

    Article  CAS  PubMed  Google Scholar 

  12. Luna-Fineman S, Shannon KM, Lange BJ . Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood 1995; 85: 1985–1999.

    CAS  PubMed  Google Scholar 

  13. Evans JP, Czepulkowski B, Gibbons B et al. Childhood monosomy 7 revisited. Br J Haematol 1988; 69: 41–45.

    Article  CAS  PubMed  Google Scholar 

  14. Sieff CA, Chessells JM, Harvey BA et al. Monosomy 7 in childhood: a myeloproliferative disorder. Br J Haematol 1981; 49: 235–249.

    Article  CAS  PubMed  Google Scholar 

  15. Festa RS, Shende A, Lanzkowsky P . Juvenile chronic myelocytic leukemia: experience with intensive combination chemotherapy. Med Pediatr Oncol 1990; 18: 311–316.

    Article  CAS  PubMed  Google Scholar 

  16. Hasle H, Kerndrup G, Yssing M et al. Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia 1996; 10: 1269–1273.

    CAS  PubMed  Google Scholar 

  17. Smith FO, King R, Nelson G et al. Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukemia. Br J Haematology 2002; 116: 716–724.

    Article  Google Scholar 

  18. Sanders JE, Buckner CD, Thomas ED et al. Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Blood 1988; 71: 1144–1146.

    CAS  PubMed  Google Scholar 

  19. Anderson JE, Appelbaum FR, Fisher LD et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 1993; 82: 677–681.

    CAS  PubMed  Google Scholar 

  20. Guinan EC, Tarbell NJ, Tantravahi R, Weinstein HJ . Bone marrow transplantation for children with myelodysplastic syndromes. Blood 1989; 73: 619–622.

    CAS  PubMed  Google Scholar 

  21. Locatelli F, Zecca M, Niemeyer C et al. Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry. Bone Marrow Transplant 1996; 18 (Suppl 2): 63–68.

    PubMed  Google Scholar 

  22. Anderson JE, Appelbaum FR, Storb R . An update on allogeneic marrow transplantation for myelodysplastic syndrome. Leuk Lymphoma 1995; 17: 95–99.

    Article  CAS  PubMed  Google Scholar 

  23. Appelbaum FR, Barrall J, Storb R et al. Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome. Ann Intern Med 1990; 112: 590–597.

    Article  CAS  PubMed  Google Scholar 

  24. Anderson JE, Anasetti C, Appelbaum FR et al. Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia. Br J Haematol 1996; 93: 59–67.

    Article  CAS  PubMed  Google Scholar 

  25. Emmanuel PD . Myelodysplastic syndrome and myeloproliferative disease in childhood: an update. Br J Haematol 1999; 105: 852–863.

    Article  Google Scholar 

  26. Dupont B, Yang S . Histocompatibility. In: Anonymous (ed.) Blackwell Scientific Publications: Boston, MA, 1994.

  27. Petersdorf EW, Smith AG, Mickelson EM et al. Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB I first domain. Immunogenetics 1991; 33: 267–275.

    Article  CAS  PubMed  Google Scholar 

  28. Thomas ED, Storb R, Clift RA et al. Bone-marrow transplantation (second of two parts). N Engl J Med 1975; 292: 895–902.

    Article  CAS  PubMed  Google Scholar 

  29. Johnson FL, Sanders JE, Ruggiero M et al. Bone marrow transplantation for the treatment of acute nonlymphoblastic leukemia in children aged less than 2 years. Blood 1988; 71: 1277–1280.

    CAS  PubMed  Google Scholar 

  30. Slattery J, Sanders J, Buckner CD, Schaffer RL . Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant 1995; 16: 31–42.

    CAS  PubMed  Google Scholar 

  31. Bearman SI, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562–1568.

    Article  CAS  PubMed  Google Scholar 

  32. Durnarn DM, Anders KR, Fisher L et al. Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood 1989; 74: 2220–2226.

    Google Scholar 

  33. Blazar BR, Orr ITF, Arthur DC et al. Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. Blood 1985; 66: 1436–1444.

    CAS  PubMed  Google Scholar 

  34. Ugozzoli L, Yam P, Petz LD et al. Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood 1991; 77: 1607–1615.

    CAS  PubMed  Google Scholar 

  35. Doney KC, Weiden PL, Storb R, Thomas ED . Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol 1981; 11: 1–8.

    Article  CAS  PubMed  Google Scholar 

  36. Sullivan KM, Shulman HM, Storb R et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267–276.

    CAS  PubMed  Google Scholar 

  37. Lansky SB, List MA, Lansky LL et al. The measurement of performance in childhood cancer patients. Cancer 1987; 60: 1651–1656.

    Article  CAS  PubMed  Google Scholar 

  38. Karnofsky D, Burchenal J . The clinical evaluation of chemotherapeutic agents in cancer. In: Anonymous (ed.) The Clinical Evaluation of Chemotherapeutic Agents in Cancer. Columbia University Press: New York, 1949.

    Google Scholar 

  39. Sanders JE . Growth and development after hematopoietic cell transplantation. In: Thomas ED, Blume KG, Forman SJ (eds). Hematopoietic cell transplantation, Chapter 65. pp 764–775.

  40. Kaplan E, Meier P . Non parametric estimation from incomplete observations. Am Stat Assoc 1957; 53: 457–481.

    Article  Google Scholar 

  41. Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695–706.

    Article  CAS  PubMed  Google Scholar 

  42. Davies SM, Wagner JE, Defor T et al. Unrelated donor bone marrow transplantation for children and adolescents with aplastic anemia or myelodysplasia. Br J Haematol 1997; 96: 749–756.

    Article  CAS  PubMed  Google Scholar 

  43. Casper J, Camitta B, Truitt R et al. Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 1995; 85: 2354–2363.

    CAS  PubMed  Google Scholar 

  44. de Witte T, Zwaan F, Hermans J et al. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). Br J Haematol 1990; 74: 151–155.

    Article  CAS  PubMed  Google Scholar 

  45. Matthews DC, Appelbaum FR, Eary JF et al. Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 13 1 I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation. Blood 1995; 85: 1122–1131.

    CAS  PubMed  Google Scholar 

  46. Runde V, de Witte T, Arnold R et al. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21: 255–261.

    Article  CAS  PubMed  Google Scholar 

  47. Woods WG, Nesbitt ME, Buckley JD et al. Correlation of chromosomal abnormalities with characteristics, histologic subtype and induction success in children with acute non-lymphoblastic leukemia (ANLL). J Clin Oncol. 1985; 3: 3–11.

    Article  CAS  PubMed  Google Scholar 

  48. Sievers EL, Lange BJ, Buckley JD et al. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. J Natl Cancer Inst 1996; 88: 1483–1488.

    Article  CAS  PubMed  Google Scholar 

  49. Antin JH, Ferrara JLN . Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964–2968.

    CAS  PubMed  Google Scholar 

  50. Vogelsang GB, Hess AD . Graft-versus-host disease: new directions for a persistent problem. Blood 1994; 84: 2061–2067.

    CAS  PubMed  Google Scholar 

  51. Petersdorf EW, Gooley TA, Anasetti C et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and 11 alleles in the donor and recipient. Blood 1998; 92: 3515–3520.

    CAS  PubMed  Google Scholar 

  52. Kishi K, Takahashi S, Gondo H et al. Second allogeneic bone marrow transplantation for post transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Bone Marrow Transplant 1997; 19: 461–466.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are indebted to Mr Chris Olson and Ms Meg Bender for their valuable assistance in the preparation of this manuscript. This study was supported in part by National Institutes of Health Grants No. HL 36444, CA 15704, CA 18029, CA 18221 and CA 47748.

Author information

Authors and Affiliations

  1. Fred Hutchinson Cancer Research Center and University of Washington Departments of Pediatrics and Medicine, Seattle, WA, USA

    U Yusuf, T A Gooley, A E Woolfrey, P A Carpenter, R G Andrews, H J Deeg, F R Appelbaum, C Anasetti, R Storb & J E Sanders

  2. Department of Pediatric Hematology/Oncology, Vanderbilt University, Nashville, TN, USA

    H A Frangoul

Authors
  1. U Yusuf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H A Frangoul
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T A Gooley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A E Woolfrey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P A Carpenter
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R G Andrews
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H J Deeg
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F R Appelbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C Anasetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. R Storb
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J E Sanders
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J E Sanders.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yusuf, U., Frangoul, H., Gooley, T. et al. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transplant 33, 805–814 (2004). https://doi.org/10.1038/sj.bmt.1704438

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704438

Keywords

This article is cited by

Search

Advanced search

Quick links